Lv57
1510 积分 2021-08-30 加入
The antibody–drug conjugate landscape
12天前
已完结
Abstract 1538: Revisiting the dogma of antibody drug conjugates (ADCs): Emerging data challenge the benefit of linker stability and the primacy of payload delivery
20天前
已完结
A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab, Lapatinib, an Anthracycline, a Taxane, and Capecitabine
20天前
已完结
Case 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer
20天前
已完结
Single β-Actin mRNA Detection in Neurons Reveals a Mechanism for Regulating Its Translatability
21天前
已完结
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
21天前
已完结
Degrader–Antibody Conjugates: Emerging New Modality
29天前
已完结
Degrader-antibody conjugates
29天前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
29天前
已完结
The antibody–drug conjugate landscape
29天前
已完结
皖公网安备34019202002308
